Saemundur Rögnvaldsson

23PUBLICATIONS
42CO-AUTHORS
Medical mycologyMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Medical molecular engineering of nucleic acids and proteinsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 14, 2026
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.

|Apr 08, 2026
Dietary intake and the risk of monoclonal gammopathy of undetermined significance: results from the population-based iStopMM screening study.

Styrmir Hallsson, Ingibjorg Gunnarsdottir, Marianna Thordardottir

|Mar 30, 2026
Revised criteria for light chain MGUS enhance diagnostic accuracy and risk stratification.

Lærke Sloth Andersen, Cecilie Velsø Mæng, Sæmundur Rögnvaldsson

|Sep 12, 2025
Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study.

Lærke Sloth Andersen, Ricardo Berenguer Navarro, Sara Ekberg

|Dec 25, 2024
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population-based screening study.

Sæmundur Rögnvaldsson, Alessandro Gasparini, Sigrun Thorsteinsdottir

|Dec 19, 2024
Approaching hypercalcemia in monoclonal gammopathy of undetermined significance: insights from the iStopMM screening study.

Ástrún Helga Jónsdóttir, Helga Ágústa Sigurjónsdóttir, Sigrun Thorsteinsdóttir

Pageof 4

Frequent Collaborators

20 joint publications

Sigrún Þorsteinsdóttir

17 joint publications

Sigurður Yngvi Kristinsson

12 joint publications

Ola Landgren

10 joint publications

Jón Þórir Óskarsson